Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.
about
Postoperative atrial fibrillation in patients undergoing non-cardiac non-thoracic surgery: A practical approach for the hospitalist2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Management Of Atrial Fibrillation In Patients With Heart FailureIn vitro and ex vivo Measurement of Prophylactic Dabigatran Concentrations with a New Ecarin-Based Thromboelastometry Test.Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches?Clinician's guide to the updated ABCs of cardiovascular disease prevention.Controversies in cardioembolic stroke.Clinical Benefit of American College of Chest Physicians versus European Society of Cardiology Guidelines for Stroke Prophylaxis in Atrial FibrillationSitagliptin After Ischemic Stroke in Type 2 Diabetic Patients: A Nationwide Cohort Study.Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future.Preserving Cognitive Function in Patients with Atrial FibrillationEvaluation Of Two Thromboembolism (TE) Risk Methods And Oral Anticoagulation Use Among Cardiac Device Patients With Atrial Tachyarrhythmias (AT).Intracranial hemorrhage during administration of a novel oral anticoagulant.Management of atrial fibrillation: What is new in the 2014 ACC/AHA/HRS guideline?Prevention and management of stroke in women.CHA2DS2-VASc Score: A Predictor of Thromboembolic Events and Mortality in Patients With an Implantable Monitoring Device Without Atrial Fibrillation.An update on insertable cardiac monitors: examining the latest clinical evidence and technology for arrhythmia management.Sex Differences in the Use of Oral Anticoagulants for Atrial Fibrillation: A Report From the National Cardiovascular Data Registry (NCDR®) PINNACLE Registry.Echocardiographic quantification of systolic function during atrial fibrillation: probing the 'ten heart cycles' rule.Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores.Managing neurogenic orthostatic hypotension with droxidopa in a patient with Parkinson disease, atrial fibrillation, and hypertension.2017 EACTS Guidelines on perioperative medication in adult cardiac surgery.Appropriateness of DOAC Prescribing Before and During Hospital Admission and Analysis of Determinants for Inappropriate Prescribing
P2860
Q26785568-3564D7D9-654F-44A7-BB12-34A40C6B04F4Q27341873-50684B9E-3071-4CB0-A8EF-B8A59931468CQ30354835-7014E5E1-3ED2-462E-A605-0B16748BACA8Q33659485-DD7C707F-9469-4ADD-B8EB-DBD9F251166DQ35026442-F3934F22-6307-4727-B101-31A5EAC8C55FQ35070830-4383FF6F-3257-4BC5-8FBC-F762643BD810Q35570827-C1E3CFED-F324-4724-A68A-EEB4236C1705Q35638248-A287228D-916E-4F4E-B9C6-3FB130012096Q36196539-0E9D63E2-43F2-4356-996D-146CF43F0795Q37164143-B0B8CF40-C3D9-4F45-B60D-2422950CC65AQ37468856-EA9911A2-ECA5-4098-A8A0-F81090A2BE12Q37468955-13944CAE-5996-47FC-AD7B-F63D04128B11Q37479416-67578376-EE4C-41DA-B20F-927DE9BDE09FQ38369003-84BCC250-EE82-4982-9A62-3CB6AB6F4785Q38369639-9C0B5932-77DB-445E-A502-4DC7E6D62247Q38372615-38B79F51-F269-46B8-9C7D-A7995C1B5624Q38506255-AF47CA8B-D80B-44FC-BF8A-FECF98563F81Q38671483-68917FF4-3577-4A50-86C2-94E38F82868FQ38903273-0DF0D910-E652-4F99-8BFF-3FF0A6E106B8Q39958030-D3570B23-AEE3-4D97-9BBC-9660B40D8341Q42336400-E4483E98-E9CA-45C9-97BE-D3EA004698F4Q50065204-A0F87C47-898E-406C-A509-81E06B53A8DCQ58697853-2F51DF81-85C6-4EBA-B2E7-A9AF2B2A7741
P2860
Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Impact of the CHA2DS2-VASc sco ...... tions for atrial fibrillation.
@ast
Impact of the CHA2DS2-VASc sco ...... tions for atrial fibrillation.
@en
type
label
Impact of the CHA2DS2-VASc sco ...... tions for atrial fibrillation.
@ast
Impact of the CHA2DS2-VASc sco ...... tions for atrial fibrillation.
@en
prefLabel
Impact of the CHA2DS2-VASc sco ...... tions for atrial fibrillation.
@ast
Impact of the CHA2DS2-VASc sco ...... tions for atrial fibrillation.
@en
P2093
P2860
P1476
Impact of the CHA2DS2-VASc sco ...... tions for atrial fibrillation.
@en
P2093
Douglas E Lake
J Michael Mangrum
J Randall Moorman
John D Ferguson
John P DiMarco
Liza P Moorman
Pamela K Mason
P2860
P304
P356
10.1016/J.AMJMED.2011.09.030
P407
P577
2012-04-11T00:00:00Z